Modified Release Neurology Therapeutics Report 2024 - Neurol

DUBLIN--(BUSINESS WIRE)--The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.com's offering.Large pharmaceutical and biotechnology companies are increasingly pursuing in-licensing to offset lower than expected drug development productivity and surging research costs. Data mining...

Related Keywords

Polyactive Octoplus , Xbrane Bipharma , Depofoam Pacira , Q Sphera Midatech Pharma , Recipharm Avadel , Fluidcrystal Camarus , Synbiosys Innocore , Transcon Ascendis , Ascendis Pharma , Laura Wood , Eli Lilly , Formulplex Supercritical Solutions , E St Office Hours Call , Critical Pharmaceuticals , Taiwan Liposome Company , Phasebio Pharmaceuticals , Route Of Administration , Formulation Technology , Novartis , Astrazeneca , Office Hours Call , Alkermes , Criticalmix Critical Pharmaceuticals , Company Profiles , Release Neurology , Topics Covered , Neurological Drugs , Injectable Device , Midatech Pharma , Supercritical Solutions , Sector Analysis , Senior Press Manager , Free Call , Hours Call ,